Business context and reporting period
Entity clarification: Despite the request metadata naming Quantum-Si Inc., this Form 10-K is for HighCape Capital Acquisition Corp., a blank-check company (SPAC), not Quantum-Si. It covers the fiscal year ended December 31, 2020, and its financial statements report activity from incorporation on June 10, 2020 through year-end. It does not provide Quantum-Si’s operating results.
HighCape completed its IPO on September 9, 2020, raising $115.0 million, and sold $4.05 million of private-placement units. On February 18, 2021, after the reporting period, it agreed to combine with Quantum-Si. The proposed transaction remained subject to stockholder approval and other closing conditions.
Financial results and position
| Metric | Reported amount or status |
|---|---|
| Operating revenue | None; HighCape had not begun operations and expected no operating revenue before a business combination. |
| Net loss | $263,139 for June 10–December 31, 2020, including $265,291 of formation and operating costs, partly offset by $2,152 of trust-account interest. |
| Operating cash flow | Cash used: $268,460. |
| Cash and trust assets at year-end | $1,034,163 outside the trust; $115,002,152 in the trust account, invested in U.S. Treasury money-market funds. |
| Liabilities and equity | Total liabilities of $4,171,558, including a $4,025,000 deferred underwriting fee payable upon a completed combination; stockholders’ equity of $5,000,004. |
| Debt and contractual commitments | No long-term debt or off-balance-sheet financing arrangements reported. HighCape paid an affiliate $10,000 monthly for office and administrative support and had the deferred underwriting fee described above. |
| Margins and profitability ratios | Not meaningful for a pre-combination SPAC with no operating revenue. |
HighCape reported no comparable prior-year operating period. IPO-related transaction costs were $6,797,377. The $115.0 million trust balance was primarily reserved for a business combination or public-share redemptions, rather than ordinary operating liquidity.
Material developments, outlook, and risks
- The proposed Quantum-Si transaction included a $425.0 million PIPE at $10 per share. A separate Foresite subscription was for 696,250 shares at $0.001 per share, following the sponsor’s forfeiture of the same number of Class B shares. These were proposed transaction terms, not 2020 operating results.
- HighCape stated the transaction required at least $160.0 million in aggregate cash proceeds from trust funds released after redemptions and PIPE proceeds. Redemptions could therefore affect the ability to close.
- HighCape disclosed potential sponsor and management conflicts, including founder-share interests, transaction-related reimbursements, and the possibility of purchases of public shares or warrants that could influence approval or reduce public float. The board did not obtain a third-party valuation or fairness opinion for the proposed transaction.
- The proposed post-combination structure included Class A shares with one vote per share and Class B shares with 20 votes per share. The filing projected that Quantum-Si founder Jonathan Rothberg would hold over 80.5% of voting power after closing, subject to transaction assumptions.
- Other cited risks included failure to complete a transaction before the stated deadline, high redemptions, dilution from warrants and new share issuance, market volatility, COVID-19 disruption, trust-account claims, potential Nasdaq listing issues, and control and governance consequences of the proposed dual-class structure.
- HighCape’s disclosure controls were assessed as effective at December 31, 2020. The 10-K did not include management’s assessment or auditor attestation of internal control over financial reporting, citing the transition period for newly public companies.
Important facts for investors to verify
- Confirm the filing identity: this is HighCape’s 2020 10-K, not Quantum-Si’s 10-K or a report of Quantum-Si’s 2020 revenue, cash flow, or profitability.
- Review the subsequent transaction filings for final closing status, actual redemptions, cash delivered, PIPE funding, share counts, and final ownership and voting control.
- Reconcile the transaction’s minimum cash condition and the trust balance with any redemptions, transaction expenses, and deferred underwriting fees.
- Check the filing’s deadline disclosures: it generally states September 9, 2022, but also includes differing references to 18 or 24 months and another date. Confirm the governing charter and any approved amendments.
- Review the audited financial statements and notes for the company’s near-minimum reported stockholders’ equity of $5,000,004, trust-account protections and creditor claims, and sponsor indemnification capacity.